Sirtuin inhibitors
- PMID: 19441904
- DOI: 10.1517/13543770902755111
Sirtuin inhibitors
Abstract
Background: The sirtuin family of deacetylase enzymes comprises seven proteins (SIRT1-7) that are dependent on NAD(+) for their activity. Three proteins are located in the nucleus, three in the mitochondria and only one is predominantly cytoplasmic. Caloric restriction and oxidative stress generally up-regulate their expression. SIRT1, the orthologue of yeast Sir2, is the mammalian sirtuin that has been most extensively studied to date. Among other targets, SIRT1 down-regulates the activity of the nuclear transcription factor p53, being this related with an increase in lifespan and cell survival associated to stress resistance.
Objective: Because sirtuin modulation could have beneficial effects on several human diseases, there is a growing interest in the discovery and development of small molecules that modify its activity. This review will be focused on sirtuin inhibitors.
Conclusions: Several specific inhibitors of SIRT1 have been described. These compounds could be mainly useful for the treatment of cancers by increasing p53 activity that stops the formation of tumours and induces apoptosis. A p53-independent massive induction of apoptosis has been also described for one inhibitor. In addition, a potent and selective SIRT2 inhibitor that ameliorates the alpha-synuclein fibril formation in Parkinson disease has been proposed to treat this kind of neurodegenerative disease.
Similar articles
-
Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect.Oncogene. 2009 Feb 12;28(6):781-91. doi: 10.1038/onc.2008.436. Epub 2008 Dec 8. Oncogene. 2009. PMID: 19060927
-
DBC1 is a negative regulator of SIRT1.Nature. 2008 Jan 31;451(7178):583-6. doi: 10.1038/nature06500. Nature. 2008. PMID: 18235501
-
Silent information regulator 2 (SIRT1) attenuates oxidative stress-induced mesangial cell apoptosis via p53 deacetylation.Free Radic Biol Med. 2006 Jun 15;40(12):2175-82. doi: 10.1016/j.freeradbiomed.2006.02.014. Epub 2006 Mar 20. Free Radic Biol Med. 2006. PMID: 16785031
-
SIRTUIN 1: regulating the regulator.Biochem Biophys Res Commun. 2008 Nov 14;376(2):251-5. doi: 10.1016/j.bbrc.2008.08.137. Epub 2008 Sep 5. Biochem Biophys Res Commun. 2008. PMID: 18774777 Review.
-
The Sirtuin family: therapeutic targets to treat diseases of aging.Curr Opin Chem Biol. 2008 Feb;12(1):11-7. doi: 10.1016/j.cbpa.2008.01.019. Epub 2008 Mar 7. Curr Opin Chem Biol. 2008. PMID: 18282481 Review.
Cited by
-
The ways and means that fine tune Sirt1 activity.Trends Biochem Sci. 2013 Mar;38(3):160-7. doi: 10.1016/j.tibs.2012.12.004. Epub 2013 Feb 7. Trends Biochem Sci. 2013. PMID: 23394938 Free PMC article. Review.
-
Trials with 'epigenetic' drugs: an update.Mol Oncol. 2012 Dec;6(6):657-82. doi: 10.1016/j.molonc.2012.09.004. Epub 2012 Oct 6. Mol Oncol. 2012. PMID: 23103179 Free PMC article. Review.
-
Sirtuin activators and inhibitors.Biofactors. 2012 Sep-Oct;38(5):349-59. doi: 10.1002/biof.1032. Epub 2012 Jun 25. Biofactors. 2012. PMID: 22730114 Free PMC article. Review.
-
Activation of the sirtuin silent information regulator 1 pathway inhibits pathological myocardial remodeling.Front Pharmacol. 2023 Feb 10;14:1111320. doi: 10.3389/fphar.2023.1111320. eCollection 2023. Front Pharmacol. 2023. PMID: 36843938 Free PMC article. Review.
-
Role of SIRT1 and Progesterone Resistance in Normal and Abnormal Endometrium.J Clin Endocrinol Metab. 2022 Feb 17;107(3):788-800. doi: 10.1210/clinem/dgab753. J Clin Endocrinol Metab. 2022. PMID: 34665857 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
